annual meeting program - American Society of Clinical Oncology

More documents

Recommendations

Info

9:30 AM - 12:30 PM ORAL ABSTRACT SESSION Gastrointestinal (Colorectal) Cancer Location: E Hall D1 CME credit: 3 Track(s): Gastrointestinal (Colorectal) Cancer Sunday, June 6, 2010 Tanios S. Bekaii-Saab, MD—Co-Chair The Ohio State University Medical Center Chris R. Garrett, MD—Co-Chair University of Texas M. D. Anderson Cancer Center 9:30 AM Phase III study of first-line XELOX plus bevacizumab (BEV) for 6 cycles followed by XELOX plus BEV or single-agent (s/a) BEV as maintenance therapy in patients (pts) with metastatic colorectal cancer (mCRC): The MACRO Trial (Spanish Cooperative Group for the Treatment of Digestive Tumors [TTD]). (Abstract #3501) J. Tabernero, E. Aranda, A. Gomez, B. Massuti, J. Sastre, A. Abad, M. Valladares, F. Rivera, M. Safont, E. Diaz-Rubio 9:45 AM Identification of potentially responsive subsets when cetuximab is added to oxaliplatin-fluoropyrimidine chemotherapy (CT) in first-line advanced colorectal cancer (aCRC): Mature results of the MRC COIN trial. (Abstract #3502) T. S. Maughan, R. Adams, C. G. Smith, M. T. Seymour, R. H. Wilson, A. M. Meade, D. Fisher, A. Madi, J. Cheadle, R. S. Kaplan, MRC COIN Trial Investigators 10:00 AM Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM). (Abstract #3526) T. Ruers, C. J. Punt, F. van Coevorden, I. Borel Rinkes, J. A. Ledermann, G. J. Poston, W. Bechstein, M. Lentz, M. Mauer, B. Nordlinger Discussion 10:15 AM Alan Paul Venook, MD (Abstracts #3501, 3502, 3526) University of California, San Francisco 10:30 AM Comparison of molecular and pathologic features of stage II and stage III colon cancer in four large studies conducted for development of the 12-gene colon cancer recurrence score. (Abstract #3503) M. J. O’Connell, I. C. Lavery, R. G. Gray, P. Quirke, D. J. Kerr, M. Lopatin, G. A. Yothers, M. Lee, K. Clark-Langone, N. Wolmark 10:45 AM Molecular and clinical determinants of survival following relapse after curative treatment of stage II-III colon cancer (CC): Results of the translational study on the PETACC 3-EORTC 40993-SAKK 60-00 trial. (Abstract #3504) A. Roth, D. Klingbiel, P. Yan, R. Fiocca, M. Delorenzi, R. Labianca, D. Cunningham, E. Van Cutsem, F. Bosman, S. Tejpar 11:00 AM Mutant KRAS and BRAF gene expression profiles in colorectal cancer: Results of the translational study on the PETACC 3-EORTC 40993-SAKK 60–00 trial. (Abstract #3505) S. Tejpar, V. Popovici, M. Delorenzi, E. Budinska, H. Estrella, M. Mao, P. Yan, S. Weinrich, E. Van Cutsem, A. Roth 11:15 AM Cetuximab with chemotherapy (CT) as first-line treatment for metastatic colorectal cancer (mCRC): Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation status. (Abstract #3506) C. Bokemeyer, C. Kohne, P. Rougier, C. Stroh, M. Schlichting, E. Van Cutsem 229 SUNDAY
SUNDAY Sunday, June 6, 2010 Discussion 11:30 AM Charles Fuchs, MD (Abstracts #3503–3506) Dana-Farber Cancer Institute 11:45 AM Adjuvant mFOLFOX6 with or without cetuxiumab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): Results from NCCTG Intergroup Phase III Trial N0147. (Abstract #CRA3507) S. R. Alberts, D. J. Sargent, T. C. Smyrk, A. F. Shields, E. Chan, R. M. Goldberg, S. Gill, M. S. Kahlenberg, S. N. Thibodeau, S. Nair 12:00 PM Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147. (Abstract #3508) R. M. Goldberg, D. J. Sargent, S. N. Thibodeau, M. R. Mahoney, A. F. Shields, E. Chan, S. Gill, M. S. Kahlenberg, S. Nair, S. R. Alberts Discussion 12:15 PM Louis M. Weiner, MD (Abstracts #CRA3507–3508) Georgetown University Medical Center 230
Page 1 and 2:
46th Annual Meeting June 4-8, 2010
Page 3 and 4:
SESSIONS AND SYMPOSIA SCIENTIFIC SE
Page 5 and 6:
SESSIONS AND SYMPOSIA continued SPE
Page 7 and 8:
ANNUAL MEETING PLANNING COMMITTEES
Page 9 and 10:
ANNUAL MEETING PLANNING COMMITTEES
Page 11 and 12:
CONTINUING MEDICAL EDUCATION INFORM
Page 13 and 14:
ONSITE DETAILS continued floor plan
Page 15 and 16:
ASCO SHUTTLE SERVICE Complimentary
Page 17 and 18:
POLICIES Important Security and Att
Page 19 and 20:
AWARDS continued 2010 Merit Awards
Page 21 and 22:
AWARDS continued 2010 Advanced Clin
Page 23 and 24:
AWARDS continued 2010 International
Page 25 and 26:
AWARDS continued 2006 YIA Paul Halu
Page 27 and 28:
2010 ANNUAL MEETING SUPPORTERS* THE
Page 29 and 30:
2010 ANNUAL MEETING SUPPORTERS cont
Page 31 and 32:
PROGRAM BY TRACK Breast Cancer cont
Page 33 and 34:
PROGRAM BY TRACK Central Nervous Sy
Page 35 and 36:
PROGRAM BY TRACK Developmental Ther
Page 37 and 38:
PROGRAM BY TRACK Gastrointestinal (
Page 39 and 40:
PROGRAM BY TRACK Genitourinary Canc
Page 41 and 42:
PROGRAM BY TRACK Gynecologic Cancer
Page 43 and 44:
PROGRAM BY TRACK International cont
Page 45 and 46:
PROGRAM BY TRACK Lymphoma and Plasm
Page 47 and 48:
PROGRAM BY TRACK Patient and Surviv
Page 49 and 50:
PROGRAM BY TRACK Pediatric Oncology
Page 51 and 52:
PROGRAM BY TRACK Professional Devel
Page 53 and 54:
PROGRAM BY TRACK Special Sessions c
Page 55 and 56:
FRIDAY Friday, June 4, 2010 1:00 PM
Page 57 and 58:
Page 59 and 60:
FRIDAY Friday, June 4, 2010 Sex and
Page 61 and 62:
Page 63 and 64:
FRIDAY Friday, June 4, 2010 Brd. 7
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
SATURDAY Saturday, June 5, 2010 7:3
Page 81 and 82:
SATURDAY Saturday, June 5, 2010 Mel
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
SATURDAY Saturday, June 5, 2010 Brd
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
SATURDAY Saturday, June 5, 2010 Dis
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
SATURDAY Saturday, June 5, 2010 Imp
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178: SATURDAY Saturday, June 5, 2010 3:0
Page 189 and 190: SUNDAY Sunday, June 6, 2010 7:30 AM
Page 193 and 194: SUNDAY Sunday, June 6, 2010 PARP In
Page 197 and 198: SUNDAY Sunday, June 6, 2010 Brd. 2D
Page 199 and 200: SUNDAY Sunday, June 6, 2010 Brd. 5F
Page 203 and 204: SUNDAY Sunday, June 6, 2010 Brd. 13
Page 227: SUNDAY Sunday, June 6, 2010 9:30 AM
Page 231 and 232: SUNDAY Sunday, June 6, 2010 Discuss
Page 241 and 242: SUNDAY Sunday, June 6, 2010 10:30 A
Page 243 and 244: SUNDAY Sunday, June 6, 2010 11:30 A
Page 245 and 246: SUNDAY Sunday, June 6, 2010 1:00 PM
Page 257 and 258: SUNDAY Sunday, June 6, 2010 Brd. 3G
Page 259 and 260: SUNDAY Sunday, June 6, 2010 Brd. 6F
Page 261 and 262: SUNDAY Sunday, June 6, 2010 Brd. 9G
Page 279 and 280:
SUNDAY Sunday, June 6, 2010 2:00 PM
Page 281 and 282:
SUNDAY Sunday, June 6, 2010 Brd. 51
Page 283 and 284:
SUNDAY Sunday, June 6, 2010 Brd. 55
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
SUNDAY Sunday, June 6, 2010 The Evo
Page 291 and 292:
MONDAY Monday, June 7, 2010 7:30 AM
Page 293 and 294:
Page 295 and 296:
MONDAY Monday, June 7, 2010 The Bio
Page 297 and 298:
Page 299 and 300:
MONDAY Monday, June 7, 2010 Brd. 7
Page 301 and 302:
MONDAY Monday, June 7, 2010 Brd. 2D
Page 303 and 304:
MONDAY Monday, June 7, 2010 Brd. 5E
Page 305 and 306:
MONDAY Monday, June 7, 2010 Brd. 8F
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
MONDAY Monday, June 7, 2010 TRIALS
Page 315 and 316:
MONDAY Monday, June 7, 2010 Breast
Page 317 and 318:
MONDAY Monday, June 7, 2010 Central
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
MONDAY Monday, June 7, 2010 11:45 A
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
MONDAY Monday, June 7, 2010 Discuss
Page 359 and 360:
MONDAY Monday, June 7, 2010 Brd. 2F
Page 361 and 362:
MONDAY Monday, June 7, 2010 Brd. 5G
Page 363 and 364:
MONDAY Monday, June 7, 2010 Brd. 9A
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
MONDAY Monday, June 7, 2010 1:00 PM
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
MONDAY Monday, June 7, 2010 NCI Com
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
TUESDAY Tuesday, June 8, 2010 7:30
Page 417 and 418:
TUESDAY Tuesday, June 8, 2010 Early
Page 419 and 420:
Page 421 and 422:
TUESDAY Tuesday, June 8, 2010 Brd.
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
show all

annual meeting program - American Society of Clinical Oncology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?